Liao Wei, Li Xiaoying, Mancini Michael, Chan Lawrence
The Department of Medicine, Division of Endocrinology and Metabolism, University of California San Diego School of Medicine, La Jolla, California 92093-0673, USA
J Cell Biochem. 2006 Nov 1;99(4):1085-95. doi: 10.1002/jcb.20996.
Liver, a central organ responsible for the metabolism of carbohydrates, proteins, and lipoproteins, is exposed to various kinds of physiological, pathological, and environmental stresses. We hypothesized that blockage of proteasome degradation pathway induces heat shock protein (HSP) response and unfolded protein response in the liver cells. In this study, we have characterized cellular responses to proteasome inhibition in HepG2 cells, a well-differentiated human hepatoma cells. We found that proteasome inhibition induced differential response among cytosolic HSPs, that is, increased expression of HSP70, but no change in HSP40, HSC70, and HSP90. However, proteasome inhibition did not induce typical unfolded protein response as indicated by absence of stimulation of GRP78 and GRP94 proteins. Upon proteasome inhibition, inclusion bodies were accumulated, and ubiquitin-conjugated proteins appeared in insoluble fraction, together with HSP40, HSP70, HSC70, and HSP90. After proteasome inhibition, misfolded proteins were increased in the cytosol and in the ER compartment as evaluated by examining ubiquitin-conjugated proteins. However, essentially all ER-associated ubiquitin-conjugated proteins were located on the surface of the ER, which explains why proteasome inhibition does not induce unfolded protein response. In conclusion, proteasome inhibition induces differential HSP response, but not unfolded protein response in HepG2 cells. Our study also suggests that HSPs play important roles in directing proteasomal degradation and protein aggregate formation.
肝脏作为负责碳水化合物、蛋白质和脂蛋白代谢的核心器官,会受到各种生理、病理和环境应激的影响。我们推测蛋白酶体降解途径的阻断会诱导肝细胞中的热休克蛋白(HSP)反应和未折叠蛋白反应。在本研究中,我们对人肝癌细胞系HepG2细胞(一种高度分化的人肝癌细胞)对蛋白酶体抑制的细胞反应进行了表征。我们发现蛋白酶体抑制会诱导胞质HSP之间的差异反应,即HSP70表达增加,但HSP40、HSC70和HSP90没有变化。然而,蛋白酶体抑制并未如GRP78和GRP94蛋白未受刺激所表明的那样诱导典型的未折叠蛋白反应。蛋白酶体抑制后,包涵体积累,泛素缀合蛋白出现在不溶性部分,同时伴有HSP40、HSP70、HSC70和HSP90。蛋白酶体抑制后,通过检测泛素缀合蛋白评估发现,胞质和内质网(ER)区室中的错误折叠蛋白增加。然而,基本上所有与ER相关的泛素缀合蛋白都位于ER表面,这解释了为什么蛋白酶体抑制不会诱导未折叠蛋白反应。总之,蛋白酶体抑制在HepG2细胞中诱导差异HSP反应,但不诱导未折叠蛋白反应。我们的研究还表明,HSP在指导蛋白酶体降解和蛋白质聚集体形成中起重要作用。